Robert J. Kelley

Insider Reports History

Reporting-owner location: Menlo Park, CA
Latest reporting-owner signature: /s/ Gillian Green, Attorney-in-fact for Robert J. Kelley
Source: Latest parsed Forms 3/4/5 signature
Transaction source note: Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Robert J. Kelley

Form 4 holding Chief Executive Officer, Director

Talis Biomedical Corp

Security class: Stock option (right to buy)
Shares / value: 500,000
Estimated value
Report date: 07 Apr 2023
Price
Ownership: Direct
Underlying class: Common Stock
Underlying amount

Insider Reports Filed by Robert J. Kelley

4

Talis Biomedical Corp

Report period: 07 Apr 2023
Transactions: 1
Transaction value: $0
Accepted by SEC: 11 Apr 2023, 16:06
Role: Chief Executive Officer, Director
Next action: Open filing details

4

Talis Biomedical Corp

Report period: 01 Jun 2022
Transactions: 1
Transaction value: $0
Accepted by SEC: 02 Jun 2022, 17:23
Role: Chief Executive Officer, Director
Next action: Open filing details

4

Talis Biomedical Corp

Report period: 08 Dec 2021
Transactions: 1
Transaction value: $0
Accepted by SEC: 09 Dec 2021, 15:14
Role: Chief Executive Officer, Director
Next action: Open filing details

4

Talis Biomedical Corp

Report period: 02 Oct 2021
Transactions: 1
Transaction value: $0
Accepted by SEC: 05 Oct 2021, 16:48
Role: Chief Commercial Officer
Next action: Open filing details

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .